Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aripiprazole Versus Placebo for Schizophrenia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436993/0/Low_molecular_weight_heparin_for_prevention_of_central_venous_catheterization_related_thrombosis_in_children:_Cochrane_systematic_review. Accessed 19 April 2024.
Aripiprazole versus placebo for schizophrenia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/0/Low_molecular_weight_heparin_for_prevention_of_central_venous_catheterization_related_thrombosis_in_children:_Cochrane_systematic_review. Accessed April 19, 2024.
Aripiprazole versus placebo for schizophrenia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/0/Low_molecular_weight_heparin_for_prevention_of_central_venous_catheterization_related_thrombosis_in_children:_Cochrane_systematic_review
Aripiprazole Versus Placebo for Schizophrenia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/0/Low_molecular_weight_heparin_for_prevention_of_central_venous_catheterization_related_thrombosis_in_children:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
ID - 436993
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/0/Low_molecular_weight_heparin_for_prevention_of_central_venous_catheterization_related_thrombosis_in_children:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -